SR 4233: A tumor specific radiosensitizer active in fractionated radiation regimes
- 31 December 1991
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 20, 151-156
- https://doi.org/10.1016/0167-8140(91)90203-s
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Keynote address: Hypoxic cell radiosensitizers: Where next?International Journal of Radiation Oncology*Biology*Physics, 1989
- Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1988
- The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: Evidence for therapeutic gainInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Acute hypoxia in tumors: Implications for modifiers of radiation effectsInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Sensitizers and radiation dose fractionation: Results and interpretationsInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Enhancement of melphalan-induced tumour cell killing by misonidazole: An interaction of competing mechanismsBritish Journal of Cancer, 1984
- Radiosensitization of hypoxic cells in vivo by SR 2508 at low radiation doses: A preliminary reportInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Carcinoma of the cervix—anaemia, radiotherapy and hyperbaric oxygenThe British Journal of Radiology, 1983
- Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gainBritish Journal of Cancer, 1982
- The Phenomenon of Reoxygenation and Its Implications for Fractionated RadiotherapyRadiology, 1972